Co-Authors
This is a "connection" page, showing publications co-authored by Mohamad Goldust and Michelangelo Vestita.
Connection Strength
2.260
-
Could isotretinoin be a protective agent against COVID-19?: A dermatologist perspective. J Cosmet Dermatol. 2021 Aug; 20(8):2394-2395.
Score: 0.237
-
Comment on "Androgens and women: COVID-19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism". Int J Dermatol. 2021 Sep; 60(9):e337-e338.
Score: 0.235
-
Cutaneous manifestation of COVID-19 reporting from Middle-Eastern countries: A point of view! Int J Dermatol. 2020 Dec; 59(12):1547-1548.
Score: 0.227
-
Comment on "Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab". Int J Dermatol. 2020 11; 59(11):1417-1418.
Score: 0.226
-
Comment on "Cutaneous manifestations of COVID-19: A case report and a new finding from Egypt". Dermatol Ther. 2020 11; 33(6):e14120.
Score: 0.225
-
Sexually transmitted COVID-19. Dermatol Ther. 2020 11; 33(6):e13982.
Score: 0.224
-
Omalizumab and COVID-19 treatment: Could it help? Dermatol Ther. 2020 Jul; 33(4):e13792.
Score: 0.223
-
Comment on "Antipsoriatic treatments during COVID-19 outbreak". Dermatol Ther. 2020 07; 33(4):e13491.
Score: 0.222
-
Systemic isotretinoin therapy in the era of COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13482.
Score: 0.221
-
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action". Dermatol Ther. 2020 07; 33(4):e13360.
Score: 0.219